Viewing Study NCT00070551


Ignite Creation Date: 2025-12-24 @ 11:57 PM
Ignite Modification Date: 2025-12-25 @ 9:54 PM
Study NCT ID: NCT00070551
Status: COMPLETED
Last Update Posted: 2013-06-04
First Post: 2003-10-03
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: GTI-2040 and High-Dose Cytarabine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia
Sponsor: National Cancer Institute (NCI)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module